Corcept Therapeutics: LIFYORLI Is Likely A Blockbuster, But The Valuation Already Knows It

Corcept Therapeutics remains a 'Hold' as LIFYORLI's strong launch and clinical demand are already reflected in a premium valuation. LIFYORLI generated $47.6M in its first full quarter, with management ...

Why fresh volatility means a 'valuation opportunity' is opening up in U.S. stocks

It's been another choppy week in markets, featuring a rebound in the artificial-intelligence trade, highly divergent share price reactions to big tech earnings, and more volatility in oil as the ...

Agnico Eagle Q2 Earnings Call Highlights Growth Pipeline

Agnico Eagle Mines LimitedAEM emphasized operational execution, capital discipline and long-term production growth during its second-quarter 2026 earnings call. Management highlighted record free cash ...

Amazon Q2 Earnings Call Highlights AI Capacity Push

Amazon.com, Inc.AMZN used its second-quarter earnings call to emphasize accelerating AWS growth, expanding artificial ...

Stefanski offers Tua update, evaluates progress of Falcons rookie QB Strand

Falcons head coach Kevin Stefanski shared an update on quarterback Tua Tagovailoa as he continues to progress following an ...